Antimo Natale

Dr. Antimo Natale

Università degli Studi di Catania, Catania, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
LFLaura Fusar-Poli
Laura Fusar-Poli
ANAntimo Natale
Antimo Natale
Andrea AmerioAndrea Amerio
Andrea Amerio
PCPatriciu Cimpoesu
Patriciu Cimpoesu
PFPietro Grimaldi Filioli
Pietro Grimaldi Filioli
Andrea AgugliaAndrea Aguglia
Andrea Aguglia
Background: Several inflammatory hypotheses have been suggested to explain the etiopathogenesis of bipolar disorder (BD) and its different phases. Neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), and monocyte-to-lymphocyte (MLR) ratios have been proposed as potential peripheral biomarkers of mood episodes. Methods: We recruited 294 patients affected by BD, of which 143 were experiencing a (hypo)manic episode and 151 were in a depressive phase. A blood sample was drawn to perform a complete blood count. NLR, PLR, and MLR were subsequently calculated. A t-test was performed to evaluate differences in blood cell counts between depressed and (hypo)manic patients and a regression model was then computed. Results: Mean values of neutrophils, platelets, mean platelet volume, NLR, PLR, and MLR were significantly higher in (hypo)manic than depressed individuals. Logistic regression showed that PLR may represent an independent predictor of (hypo)mania. Conclusions: Altered inflammatory indexes, particularly PLR, may explain the onset and recurrence of (hypo)manic episodes in patients with BD. As inflammatory ratios represent economical and accessible markers of inflammation, further studies should be implemented to better elucidate their role as peripheral biomarkers of BD mood episodes.

28 February 2021 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
LFLaura Fusar-Poli
Laura Fusar-Poli
ARAlessandro Rodolico
Alessandro Rodolico
SSSerena Sturiale
Serena Sturiale
BCBianca Carotenuto
Bianca Carotenuto
ANAntimo Natale
Antimo Natale
Eugenio AgugliaEugenio Aguglia
Eugenio Aguglia
Laura Fusar-Poli*, Alessandro Rodolico*, Serena Sturiale, Bianca Carotenuto, Antimo Natale, Davide Arillotta, Spyridon Siafis, Maria Salvina Signorelli, Eugenio Aguglia. Clin Psychopharmacol Neurosci 2021;19:26-45. https://doi.org/10.9758/cpn.2021.19.1.26

12 March 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
LFLaura Fusar-Poli
Laura Fusar-Poli
Andrea AmerioAndrea Amerio
Andrea Amerio
PCPatriciu Cimpoesu
Patriciu Cimpoesu
PFPietro Grimaldi Filioli
Pietro Grimaldi Filioli
ANAntimo Natale
Antimo Natale
Andrea AgugliaAndrea Aguglia
Andrea Aguglia
Background: Evidence suggested that inflammation may be involved in the etiopathogenesis of bipolar disorder (BD), a chronic psychiatric condition affecting around 2–3% of the general population. However, little is known regarding potential gender differences in peripheral biomarkers of BD, such as neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), and monocyte-to-lymphocyte (MLR) ratios. Methods: In total, 197 females and 174 males with BD in different phases (i.e., (hypo)mania, depression, euthymia) were recruited. A blood sample was drawn to perform a complete blood count (CBC). NLR, PLR, and MLR were subsequently calculated, and differences were computed according to the illness phase and gender. Results: PLR was consistently higher in (hypo)manic than depressed patients, in both males and females. No significant gender differences in PLR value were found when considering only (hypo)mania. Conversely, NLR was increased in (hypo)mania only among males, and gender differences were retrieved in the (hypo)manic subgroup. The findings related to MLR were only marginally significant. Higher platelets values were associated with (hypo)mania only in the female group. Basophils and eosinophils appeared gender- but not state-dependent. Conclusions: Our findings provide further evidence that increased PLR levels may be associated with (hypo)mania in bipolar patients, regardless of gender. Moreover, the usefulness of NLR as a peripheral biomarker of BD appeared limited to males while the role of platelets to females. As CBC represents a low-cost and easily accessible test, researchers should investigate in-depth its potential usefulness as a biomarker of BD and other psychiatric disorders.

30 December 2020 in Medicina
Verified
Journal Article
Open access
PDF file
LFLaura Fusar-Poli
Laura Fusar-Poli
Andrea AmerioAndrea Amerio
Andrea Amerio
PCPatriciu Cimpoesu
Patriciu Cimpoesu
ANAntimo Natale
Antimo Natale
VSVirginio Salvi
Virginio Salvi
Andrea AgugliaAndrea Aguglia
Andrea Aguglia
Background and Objectives: Bipolar disorder (BD) is a severe mental condition with a lifetime prevalence estimated around 2% among the general population. Due to risk factors, etiological mechanisms, and the chronic use of psychotropic medications, people with BD are frequently affected by medical comorbidities, such as metabolic syndrome (MetS), associated with altered blood levels of glucose, cholesterol, and triglycerides. Moreover, the lipid concentration may be associated with the severity of psychiatric symptoms. Materials and Methods: Five hundred and forty-two in- and outpatients (418 affected by BD and 124 affected by schizophrenia) were recruited in two Italian university hospitals. A blood examination assessing the fasting glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides was performed. Results: No significant differences were found in the lipid and glycemic profiles between patients with BD and schizophrenia. When considering only the BD sample, we found that patients experiencing a manic episode had significantly lower total cholesterol, HDL, and LDL than euthymic patients. Moreover, the total and LDL cholesterol levels were significantly lower in (hypo)manic than depressed patients. Mood episodes did not influence the triglyceride and glucose levels in our sample. Conclusions: Clinicians should pay attention to blood cholesterol levels in patients with BD, as differences in concentrations may predispose them to severe medical conditions and can be associated with the onset of mood episodes.

11 January 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ANAntimo Natale
Antimo Natale
LMLudovico Mineo
Ludovico Mineo
LFLaura Fusar-Poli
Laura Fusar-Poli
Andrea AgugliaAndrea Aguglia
Andrea Aguglia
ARAlessandro Rodolico
Alessandro Rodolico
Eugenio AgugliaEugenio Aguglia
Eugenio Aguglia
The debate on mixed states (MS) has been intense for decades. However, several points remain controversial from a nosographic, diagnostic, and therapeutic point of view. The different perspectives that have emerged over the years have turned into a large, but heterogeneous, literature body. The present review aims to summarize the evidence on MS, with a particular focus on mixed depression (MxD), in order to provide a guide for clinicians and encourage the development of future research on the topic. First, we review the history of MS, focusing on their different interpretations and categorizations over the centuries. In this section, we also report alternative models to traditional nosography. Second, we describe the main clinical features of MxD and list the most reliable assessment tools. Finally, we summarize the recommendations provided by the main international guidelines for the treatment of MxD. Our review highlights that the different conceptualizations of MS and MxD, the variability of clinical pictures, and the heterogeneous response to pharmacological treatment make MxD a real challenge for clinicians. Further studies are needed to better characterize the phenotypes of patients with MxD to help clinicians in the management of this delicate condition.

31 December 2021 in Clinical Practice & Epidemiology in Mental Health
Verified
Journal Article
Open access
PDF file
LMLudovico Mineo
Ludovico Mineo
ARAlessandro Rodolico
Alessandro Rodolico
Carmen ConcertoCarmen Concerto
Carmen Concerto
ANAntimo Natale
Antimo Natale
MPManuela Pennisi
Manuela Pennisi
Eugenio AgugliaEugenio Aguglia
Eugenio Aguglia
Background: The Diagnostic and Statistical Manual for Mental Disorders (5th edition) introduced the specifier “with Mixed Features” to the diagnosis of Major Depressive Episode to designate the presence of (hypo) manic symptoms as part of the clinical presentation. This change has led to renewed attention on the operational definition, diagnosis, and treatment of Mixed Depression. Objective: To investigate the diagnostic and therapeutic approaches towards Mixed Depression among a representative sample of Italian psychiatrists. Methods: Between March and April 2021, 342 psychiatrists working in Italian adult mental health services were invited to participate in an anonymous online survey comprising 32 questions designed to investigate clinical and psychopathological approaches regarding the management of mixed depression in daily psychiatric practice. Results: 83.74% of participants reported having performed a diagnosis of mixed depression in the last five years, with the majority of respondents affirming that they had not used any diagnostic tool. Only 7,5% of the surveyed psychiatrists considered the DSM-5 criteria to be fully adequate in the description of this clinical entity. The most used pharmacological approach was combined therapy, in particular antipsychotics plus mood stabilizers. For monotherapy, the preferred drugs were Valproate and Quetiapine. Regarding the conceptualization of mood disorders, 199 of the participants chose the Kraepelinian unitary spectrum view; meanwhile, 101 expressed their preference for the binary model. Conclusion: Our results suggest a prominent position of mixed depression in the context of mood disorders. Univocal operational criteria and additional research on pharmacological treatment are also needed to ensure the correct recognition and management of mixed depression.